Apply for the ISSCR Lawrence Goldstein Science Policy Fellowship

  • 12 July, 2021
News from ISSCR website tile

Stem cell science advocacy and public policy training for early-career scientists

13 July, 2021 - The ISSCR is accepting applications through 1 September 2021 for the next class of Lawrence Goldstein Science Policy Fellows. The three-year program offers fellows access to advocacy and public policy training, ISSCR leaders, participation in advocacy events, and an ex officio seat on ISSCR’s Public Policy Committee.

Benefits and Hands-on Experience

--Attend the ISSCR Washington D.C. Advocacy Day or a policy meeting in another region of the world;

--Participate in regularly scheduled Committee calls and in-person meetings at the ISSCR annual meeting;

--Assist the Committee with projects and programs as assigned; and

--Work actively with Committee members on policy messaging and communications.

Learn more about the current class of Lawrence Goldstein Fellows (listed below) and listen to the latest episode of The Stem Cell Report podcast, where they are joined by ISSCR Public Policy Chair Sean Morrison to talk about the global problem of unproven stem cell-based “treatments” and rogue clinics.

Mohamed Abou El-Enei, MD, PhD, MSPH Keck School of Medicine, University of Southern California, USA
Zubin Master, PhD, Mayo Clinic, USA
Kirstin Matthews, PhD, Baker Institute for Public Policy, Rice University, USA

About Lawrence Goldstein
For the last 25 years, Dr. Goldstein has been a faculty member and directed a biomedical research laboratory at the University of California San Diego School of Medicine. He also founded and directed the UCSD Stem Cell Program and the Sanford Stem Cell Clinical Center and is founding scientific director of the Sanford Consortium for Regenerative Medicine. Goldstein co-chaired the scientific advisory board for California’s Proposition 71 that established three billion dollars for stem cell medical research in the state. He served on the ISSCR Board of Directors, the Task Force on Unproven Stem Cell Therapies, and Task Force on Guidelines for the Conduct of Human Embryonic Stem Cell Research; he has been a member of the Public Policy and Ethics Committees. Throughout his career, Goldstein has advocated for science before local, state, and national policy makers on issues such as decisions about funding levels, and guidelines and ethical standards for research using stem cells, fetal tissue, and other issues.  Goldstein’s lab focuses on understanding the molecular mechanisms involved in movement inside neurons and how these systems are affected in Alzheimer’s and Huntington’s Diseases.